Skip to main content
Genix Pharmaceuticals Corporation logo

Genix Pharmaceuticals Corporation — Investor Relations & Filings

Ticker · GENX ISIN · CA37232A1093 LEI · 52990086O9FPM8QVNI53 TSXV Manufacturing
Filings indexed 136 across all filing types
Latest filing 2022-09-14 Regulatory Filings
Country CA Canada
Listing TSXV GENX

About Genix Pharmaceuticals Corporation

https://genixpharm.com/

Genix Pharmaceuticals Corporation is an innovative life sciences company focused on the research, development, manufacturing, licensing, sales, and distribution of novel, branded, and generic products. The company operates as a formulator and marketer of life sciences-related products, specializing primarily in two key areas: nutraceuticals and ophthalmic solutions. Genix is committed to providing high-quality, affordable health solutions to patients through generic drugs, novel over-the-counter (OTC) products, and nutraceuticals. A core strategic focus is the prevention and management of chronic diseases, addressing conditions such as those associated with diabetes and hypertension.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2022-09-14 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-09-14 English
News release - English.pdf
Regulatory Filings
2022-09-07 English
News release - English.pdf
Regulatory Filings
2022-07-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-06-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.